Weston A P, Badr A S, Hassanein R S
The Veterans Administration Medical Center, Kansas City, Missouri, USA.
Am J Gastroenterol. 1999 Dec;94(12):3413-9. doi: 10.1111/j.1572-0241.1999.01602.x.
Our goal was a prospective follow-up of Barrett's esophagus to determine what clinical, endoscopic, and histological features at the time of initial diagnosis are predictive of the development of Barrett's adenocarcinoma or multifocal high-grade dysplasia (HGD).
Newly diagnosed Barrett's esophagus patients were prospectively followed with a standardized endoscopic and bioptic surveillance protocol. Features examined by chi2 and stepwise logistic regression analyses as potential predictors the development of multifocal HGD or adenocarcinoma included age, length of Barrett's segment, hiatal hernia size, severity of dysplasia at diagnosis, severity of dysplasia during surveillance, and type of long-term medical treatment.
One hundred-eight Barrett's patients have had follow-up ranging from 12 months to 101 months (mean +/- SD, 39.9+/-20.8 months), for a total of 361.8 patient-years. Overall, five patients developed multifocal HGD and five developed adenocarcinoma. The incidence of adenocarcinoma as well as multifocal HGD was 1 per 71.9 patient-years. Chi2 analysis showed progression to Barrett's multifocal HGD/adenocarcinoma was associated with hiatal hernia (p = 0.02), the length of Barrett's (p = 0.001), the presence of dysplasia at diagnoses (p < 0.001) or anytime during surveillance (p < 0.001). Stepwise logistic regression analysis revealed progression to multifocal HGD or adenocarcinoma was significantly and independently associated with presence of dysplasia at diagnosis (p < 0.0001) or anytime during follow-up (p < 0.03), hiatal hernia size (p < 0.02, for hernia > or =3 cm), and length of Barrett's (p = 0.009, >2 cm).
Endoscopic and histological features of Barrett's esophagus patients at initial diagnosis are predictive of risk of progression to cancer.
我们的目标是对巴雷特食管进行前瞻性随访,以确定初始诊断时的哪些临床、内镜和组织学特征可预测巴雷特腺癌或多灶性高级别异型增生(HGD)的发生。
对新诊断的巴雷特食管患者采用标准化的内镜和活检监测方案进行前瞻性随访。通过卡方检验和逐步逻辑回归分析作为多灶性HGD或腺癌发生的潜在预测因素进行检查的特征包括年龄、巴雷特段长度、食管裂孔疝大小、诊断时异型增生的严重程度、监测期间异型增生的严重程度以及长期药物治疗类型。
108例巴雷特食管患者接受了12个月至101个月的随访(平均±标准差,39.9±20.8个月),总计361.8患者年。总体而言,5例患者发生了多灶性HGD,5例发生了腺癌。腺癌以及多灶性HGD的发病率为每71.9患者年1例。卡方分析显示进展为巴雷特多灶性HGD/腺癌与食管裂孔疝(p = 0.02)、巴雷特段长度(p = 0.001)、诊断时存在异型增生(p < 0.001)或监测期间任何时间(p < 0.001)相关。逐步逻辑回归分析显示进展为多灶性HGD或腺癌与诊断时(p < 0.0001)或随访期间任何时间(p < 0.03)存在异型增生、食管裂孔疝大小(疝≥3 cm时,p < 0.02)以及巴雷特段长度(>2 cm时,p = 0.009)显著且独立相关。
巴雷特食管患者初始诊断时的内镜和组织学特征可预测癌症进展风险。